David Shaw’s Celularity CELU Stock Holding History

David Shaw’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,138	Closed	-$6.06K	–	4279
2023 Q2	$6.06K	Buy	+1,138	New	+$7.29K	﹤0.01%	4096
2023 Q1	–	Sell	-7,604	Closed	-$98.1K	–	4482
2022 Q4	$98.1K	Buy	+7,604	New	+$140K	﹤0.01%	4367

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's CELU Position: Q3 2023 in Review

David Shaw sold out of Celularity (CELU) in Q3 2023, closing a stake of 1,138 shares — an estimated $6.06K sold.

David Shaw first reported a position in CELU in Q4 2022 and held it in 2 quarters. The position peaked at $98.1K in Q4 2022. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

David Shaw reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
David Shaw sold 1,138 Celularity shares in Q3 2023, an estimated $6.06K.
David Shaw first reported a position in Celularity in Q4 2022 and held it in 2 quarters.
David Shaw's Celularity position peaked at $98.1K in Q4 2022.
45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.